Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.

Identifieur interne : 00A956 ( Main/Exploration ); précédent : 00A955; suivant : 00A957

Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.

Auteurs : R K Shenoy [Inde] ; S. Dalia ; A. John ; T K Suma ; V. Kumaraswami

Source :

RBID : pubmed:10707109

Descripteurs français

English descriptors

Abstract

Several new chemotherapeutic tools are now available for the control of lymphatic filariasis. Combinations of single doses of antifilarial drugs are generally superior to single drugs. The efficacy and safety of albendazole in combination with diethylcarbamazine (DEC) or ivermectin, for the treatment of Brugia malayi infection, were investigated, for the first time, in an open, hospital-based study. Fifty-one asymptomatic microfilaraemics (with 108-4034 microfilariae/ml; median = 531) of both sexes and aged 14-70 years were randomly allocated to receive single-dose treatments of ivermectin (200 micrograms/kg) with diethylcarbamazine (DEC; 6 mg/kg), ivermectin (200 micrograms/kg) with albendazole (400 mg), DEC (6 mg/kg) with albendazole (400 mg), or albendazole (400 mg) alone. Albendazole alone had no effect on the microfilarial levels at the 1-year follow-up but both groups given DEC had significantly lower microfilaraemias (P < 0.015 and P < 0.02) than that given ivermectin with albendazole. Overall, 47%-64% of those given DEC but only 14% of those given ivermectin with albendazole appeared to be amicrofilaraemic 1 year post-treatment. The adverse reactions seen in the study were mild, transient and qualitatively similar to those seen earlier with ivermectin and DEC. The combination of DEC and albendazole, both well tested drugs, offers a new option for countries such as India where there is no onchocerciasis or loiasis and where ivermectin may not be immediately available. The direct and indirect effects of albendazole on intestinal helminths would be additional benefits.

PubMed: 10707109


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.</title>
<author>
<name sortKey="Shenoy, R K" sort="Shenoy, R K" uniqKey="Shenoy R" first="R K" last="Shenoy">R K Shenoy</name>
<affiliation wicri:level="1">
<nlm:affiliation>Filariasis Chemotherapy Unit, T.D. Medical College Hospital, Alappuzha, India. rkshenoy@md3.vsnl.net.in</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Filariasis Chemotherapy Unit, T.D. Medical College Hospital, Alappuzha</wicri:regionArea>
<wicri:noRegion>Alappuzha</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Dalia, S" sort="Dalia, S" uniqKey="Dalia S" first="S" last="Dalia">S. Dalia</name>
</author>
<author>
<name sortKey="John, A" sort="John, A" uniqKey="John A" first="A" last="John">A. John</name>
</author>
<author>
<name sortKey="Suma, T K" sort="Suma, T K" uniqKey="Suma T" first="T K" last="Suma">T K Suma</name>
</author>
<author>
<name sortKey="Kumaraswami, V" sort="Kumaraswami, V" uniqKey="Kumaraswami V" first="V" last="Kumaraswami">V. Kumaraswami</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1999">1999</date>
<idno type="RBID">pubmed:10707109</idno>
<idno type="pmid">10707109</idno>
<idno type="wicri:Area/PubMed/Corpus">004B16</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004B16</idno>
<idno type="wicri:Area/PubMed/Curation">004B16</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004B16</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004B16</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004B16</idno>
<idno type="wicri:Area/Ncbi/Merge">000281</idno>
<idno type="wicri:Area/Ncbi/Curation">000281</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000281</idno>
<idno type="wicri:doubleKey">0003-4983:1999:Shenoy R:treatment:of:the</idno>
<idno type="wicri:Area/Main/Merge">00AF15</idno>
<idno type="wicri:Area/Main/Curation">00A956</idno>
<idno type="wicri:Area/Main/Exploration">00A956</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.</title>
<author>
<name sortKey="Shenoy, R K" sort="Shenoy, R K" uniqKey="Shenoy R" first="R K" last="Shenoy">R K Shenoy</name>
<affiliation wicri:level="1">
<nlm:affiliation>Filariasis Chemotherapy Unit, T.D. Medical College Hospital, Alappuzha, India. rkshenoy@md3.vsnl.net.in</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Filariasis Chemotherapy Unit, T.D. Medical College Hospital, Alappuzha</wicri:regionArea>
<wicri:noRegion>Alappuzha</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Dalia, S" sort="Dalia, S" uniqKey="Dalia S" first="S" last="Dalia">S. Dalia</name>
</author>
<author>
<name sortKey="John, A" sort="John, A" uniqKey="John A" first="A" last="John">A. John</name>
</author>
<author>
<name sortKey="Suma, T K" sort="Suma, T K" uniqKey="Suma T" first="T K" last="Suma">T K Suma</name>
</author>
<author>
<name sortKey="Kumaraswami, V" sort="Kumaraswami, V" uniqKey="Kumaraswami V" first="V" last="Kumaraswami">V. Kumaraswami</name>
</author>
</analytic>
<series>
<title level="j">Annals of tropical medicine and parasitology</title>
<idno type="ISSN">0003-4983</idno>
<imprint>
<date when="1999" type="published">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Albendazole (therapeutic use)</term>
<term>Animals</term>
<term>Brugia malayi</term>
<term>Diethylcarbamazine (therapeutic use)</term>
<term>Drug Administration Schedule</term>
<term>Drug Therapy, Combination</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Female</term>
<term>Filaricides (therapeutic use)</term>
<term>Humans</term>
<term>Ivermectin (therapeutic use)</term>
<term>Male</term>
<term>Microfilariae</term>
<term>Middle Aged</term>
<term>Parasitemia (drug therapy)</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Albendazole (usage thérapeutique)</term>
<term>Animaux</term>
<term>Association de médicaments</term>
<term>Brugia malayi</term>
<term>Calendrier d'administration des médicaments</term>
<term>Diéthylcarbamazine (usage thérapeutique)</term>
<term>Femelle</term>
<term>Filaricides (usage thérapeutique)</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Humains</term>
<term>Ivermectine (usage thérapeutique)</term>
<term>Microfilaria</term>
<term>Mâle</term>
<term>Parasitémie (traitement médicamenteux)</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Albendazole</term>
<term>Diethylcarbamazine</term>
<term>Filaricides</term>
<term>Ivermectin</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Elephantiasis, Filarial</term>
<term>Parasitemia</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Filariose lymphatique</term>
<term>Parasitémie</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Albendazole</term>
<term>Diéthylcarbamazine</term>
<term>Filaricides</term>
<term>Ivermectine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Animals</term>
<term>Brugia malayi</term>
<term>Drug Administration Schedule</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Microfilariae</term>
<term>Middle Aged</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Animaux</term>
<term>Association de médicaments</term>
<term>Brugia malayi</term>
<term>Calendrier d'administration des médicaments</term>
<term>Femelle</term>
<term>Humains</term>
<term>Microfilaria</term>
<term>Mâle</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Several new chemotherapeutic tools are now available for the control of lymphatic filariasis. Combinations of single doses of antifilarial drugs are generally superior to single drugs. The efficacy and safety of albendazole in combination with diethylcarbamazine (DEC) or ivermectin, for the treatment of Brugia malayi infection, were investigated, for the first time, in an open, hospital-based study. Fifty-one asymptomatic microfilaraemics (with 108-4034 microfilariae/ml; median = 531) of both sexes and aged 14-70 years were randomly allocated to receive single-dose treatments of ivermectin (200 micrograms/kg) with diethylcarbamazine (DEC; 6 mg/kg), ivermectin (200 micrograms/kg) with albendazole (400 mg), DEC (6 mg/kg) with albendazole (400 mg), or albendazole (400 mg) alone. Albendazole alone had no effect on the microfilarial levels at the 1-year follow-up but both groups given DEC had significantly lower microfilaraemias (P < 0.015 and P < 0.02) than that given ivermectin with albendazole. Overall, 47%-64% of those given DEC but only 14% of those given ivermectin with albendazole appeared to be amicrofilaraemic 1 year post-treatment. The adverse reactions seen in the study were mild, transient and qualitatively similar to those seen earlier with ivermectin and DEC. The combination of DEC and albendazole, both well tested drugs, offers a new option for countries such as India where there is no onchocerciasis or loiasis and where ivermectin may not be immediately available. The direct and indirect effects of albendazole on intestinal helminths would be additional benefits.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Inde</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Dalia, S" sort="Dalia, S" uniqKey="Dalia S" first="S" last="Dalia">S. Dalia</name>
<name sortKey="John, A" sort="John, A" uniqKey="John A" first="A" last="John">A. John</name>
<name sortKey="Kumaraswami, V" sort="Kumaraswami, V" uniqKey="Kumaraswami V" first="V" last="Kumaraswami">V. Kumaraswami</name>
<name sortKey="Suma, T K" sort="Suma, T K" uniqKey="Suma T" first="T K" last="Suma">T K Suma</name>
</noCountry>
<country name="Inde">
<noRegion>
<name sortKey="Shenoy, R K" sort="Shenoy, R K" uniqKey="Shenoy R" first="R K" last="Shenoy">R K Shenoy</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00A956 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00A956 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:10707109
   |texte=   Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:10707109" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024